Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.

Pascal KE, Dudgeon D, Trefry JC, Anantpadma M, Sakurai Y, Murin CD, Turner HL, Fairhurst J, Torres M, Rafique A, Yan Y, Badithe A, Yu K, Potocky T, Bixler SL, Chance TB, Pratt WD, Rossi FD, Shamblin JD, Wollen SE, Zelko JM, Carrion R Jr, Worwa G, Staples HM, Burakov D, Babb R, Chen G, Martin J, Huang TT, Erlandson K, Willis MS, Armstrong K, Dreier TM, Ward AB, Davey RA, Pitt MLM, Lipsich L, Mason P, Olson W, Stahl N, Kyratsous CA.

J Infect Dis. 2018 Nov 22;218(suppl_5):S612-S626. doi: 10.1093/infdis/jiy285.

2.

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.

Pascal KE, Coleman CM, Mujica AO, Kamat V, Badithe A, Fairhurst J, Hunt C, Strein J, Berrebi A, Sisk JM, Matthews KL, Babb R, Chen G, Lai KM, Huang TT, Olson W, Yancopoulos GD, Stahl N, Frieman MB, Kyratsous CA.

Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8738-43. doi: 10.1073/pnas.1510830112. Epub 2015 Jun 29.

3.

Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis.

Libby EK, Pascal KE, Mordechai E, Adelson ME, Trama JP.

Microbes Infect. 2008 Apr;10(4):439-46. doi: 10.1016/j.micinf.2008.01.004. Epub 2008 Jan 12.

PMID:
18403235
4.

Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway.

Hilbert DW, Pascal KE, Libby EK, Mordechai E, Adelson ME, Trama JP.

Microbes Infect. 2008 Feb;10(2):114-21. doi: 10.1016/j.micinf.2007.10.012. Epub 2007 Oct 26.

PMID:
18248759
5.

Rapid detection of Atopobium vaginae and association with organisms implicated in bacterial vaginosis.

Trama JP, Pascal KE, Zimmerman J, Self MJ, Mordechai E, Adelson ME.

Mol Cell Probes. 2008 Apr;22(2):96-102. Epub 2007 Aug 24.

PMID:
17913456

Supplemental Content

Loading ...
Support Center